invasive fungal infection Clinical Trials in Durham, North Carolina
2 recruitingDurham, North Carolina
Showing 1–2 of 2 trials
Recruiting
Phase 2
Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
invasive fungal infection
Merck Sharp & Dohme LLC40 enrolled26 locationsNCT04665037
Recruiting
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal InfectionsPulmonary Invasive Aspergillosis
Arkansas Children's Hospital Research Institute400 enrolled33 locationsNCT03827694